№ lp_2_1_31611
File format: docx
Character count: 2634
File size: 118 KB
Instructional veterinary handout issued by Hope Vets outlining step-by-step procedures for preparing, administering, and disposing of subcutaneous injections for pets at home, with references to external video guidance on YouTube and diabetes resources.
Organisation:
Hope Vets
Address:
Shantock Hall Lane, Bovingdon, HP3 0NQ
Telephone:
01442 833198
Email:
[email protected]
Website:
www.hopevets.com
Document type:
Instructional handout
Subject:
Administration of subcutaneous injections in pets
Medications mentioned:
Cytopoint, Librela, Solensia, Zycortal, insulin
Intended audience:
Pet owners administering injections at home
Related resources:
YouTube videos; Caninsulin website
Sharps disposal guidance:
Return to veterinary practice; use of sharps container or sealed container
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2020
Region / city:
Australia
Topic:
Biosimilar medicine submission
Document type:
Pharmaceutical submission
Organization / institution:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Maxx Pharma Pty Ltd
Target audience:
Healthcare professionals, regulatory bodies
Period of validity:
Ongoing
Approval date:
November 2022
Modification date:
November 2022
Note:
Year
Topic:
Lipid disorders, Cardiovascular Risk
Document Type:
Medical guideline
Target Audience:
Medical professionals, healthcare providers
Year:
2023
Region / city:
UK
Topic:
Medical procedures, Informed consent, Physiotherapy
Document type:
Guidelines
Author:
Chartered Society of Physiotherapists
Target audience:
Healthcare professionals, Physiotherapists
Date of approval:
2023
Date of changes:
N/A
Year:
2022
Region / City:
ACT and surrounding NSW
Topic:
Paediatric Diabetes Care, Insulin Pump Therapy
Document Type:
Clinical Guideline
Organization:
Canberra Health Services (CHS)
Author:
Canberra Health Services, Paediatric Endocrinology and Diabetes Service
Target Audience:
Paediatric Diabetes Healthcare Providers
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Revision:
N/A
Version number:
6.0
Approved by:
Medicines Committee
Ratified by:
Medicines Committee
Date ratified:
June 2023
Original author:
Luton & Bedfordshire Lead Pharmacist
Executive Director lead:
Chief Medical Officer
Implementation Date:
July 2023
Last Review Date:
June 2023
Next Review Date:
June 2026
Services:
Trustwide, Mental Health and LD, Community Health Services
Type of document:
Policy
Scope:
Long-acting antipsychotic injections, typical and atypical
Target audience:
Clinicians, pharmacists, mental health services staff
Document structure:
Includes guidance on initiation, choice, and monitoring of depot injections, adverse effect reporting, and appendices with forms and rating scales
Year:
2016
Region / City:
United States
Topic:
Ophthalmology, Risk Management
Document Type:
Risk Management Recommendations
Organization / Institution:
OMIC
Author:
Anne M. Menke, Pauline Merrill, Trexler M. Topping, George Williams
Target Audience:
Ophthalmologists, Healthcare Providers
Period of Validity:
Not specified
Approval Date:
8/26/16
Date of Changes:
Not specified
Year:
2019
Region / City:
New Delhi, India
Sector:
Energy
Document Type:
Request for Qualification
Organization:
REC Transmission Projects Company Ltd.
Author:
REC Transmission Projects Company Ltd.
Target Audience:
Potential Bidders for Transmission Service Provider
Period of Validity:
Until 08.02.2019
Approval Date:
12th January 2019
Amendments Date:
Not provided
Year:
2025
Region / City:
England
Subject:
Healthcare / NHS
Document Type:
Official communication
Organization / Institution:
NHS England
Author:
Erika Sutcliffe
Target Audience:
Healthcare professionals involved in NHS primary care
Effective Period:
From 1st May 2025
Approval Date:
28th May 2025
Date of Changes:
28th May 2025
Year:
2015
Region / Institution:
United Kingdom, Royal College of Radiologists
Subject:
Patient safety and documentation in intra-articular injections
Document type:
Audit report
Authors:
Dr Andrew Koo, Dr Daniel Fascia; Updated by P Mehrotra (2018), D Remedios (2022)
Target audience:
Radiologists, clinical staff performing joint injections
Review date:
23 July 2022
Publication date:
24 June 2015
Indicators:
Documentation of type, volume, and concentration of local anaesthetic agents
Methodology:
Collection of patient data from RIS, adherence to WHO and RCR safety guidelines
Recommendations:
Use of WHO checklist, departmental guidelines, and report macros for documentation
Year:
2026
Region / City:
Louisiana, Baton Rouge
Subject:
Procurement of Hydroxocobalamin Injections
Document Type:
Invitation to Bid / Procurement Terms
Agency:
Louisiana Department of Health, Office of State Procurement
RFx Number:
3000025811
Bid Submission Deadline:
03/04/2026 @ 10:00 A.M. (Central Time)
Inquiry Deadline:
02/18/2026
Response to Inquiries Deadline:
02/25/2026
Delivery Instructions:
Physical or online submission to Office of State Procurement
Payment Terms:
Unit price compensation, full delivery not required for partial payment
Authorized Contact:
Alex Jackson
Website for Registration:
https://lagoverpvendor.doa.louisiana.gov/irj/portal/anonymous?guest_user=self_reg
Online Bid Portal:
LaPAC
Year:
2022
Region / city:
N/A
Subject:
Platelet rich plasma (PRP) therapy
Document type:
Clinical guideline
Institution:
HERC
Author:
N/A
Target audience:
Healthcare professionals, researchers
Period of validity:
N/A
Approval date:
March 2022
Date of amendments:
N/A
Year:
2026
Databases:
PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials, Scopus, Sinomed
Topic:
Shoulder impingement syndrome
Intervention:
Corticosteroid injection under ultrasound guidance
Study design:
Randomized controlled trials
Number of records identified:
48–86 per database
Search terms:
Disease, Study design, Corticosteroids, Intervention
Language:
English
Document type:
Supplementary material
Year:
2023
Region / City:
Australia
Subject:
Chronic migraine, medicinal product submission
Document type:
Submission for PBS listing
Organization:
Novartis Pharmaceuticals Australia Pty. Limited
Author:
Not specified
Target audience:
Health professionals, pharmaceutical regulatory bodies
Period of validity:
Not specified
Date of approval:
2 July 2018
Date of amendments:
November 2023
Note:
Year
Theme:
Rheumatology, Methotrexate Therapy, Drug Interaction
Document Type:
Medical Guidelines
Target Audience:
Healthcare Professionals, Specialists
Year:
2021
Region / city:
Canberra
Topic:
Subcutaneous Medication Administration in Palliative Care
Document Type:
Procedure
Organization / institution:
Canberra Health Services
Author:
Canberra Health Services
Target audience:
Healthcare professionals, specifically nursing staff in palliative care settings
Period of validity:
Ongoing
Approval Date:
2021
Amendment Date:
Not specified
Year:
2022
Region / City:
ACT and surrounding NSW
Topic:
Paediatric Diabetes Care, Insulin Pump Therapy
Document Type:
Clinical Guideline
Organization:
Canberra Health Services (CHS)
Author:
Canberra Health Services, Paediatric Endocrinology and Diabetes Service
Target Audience:
Paediatric Diabetes Healthcare Providers
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Revision:
N/A
Year:
2026
Region / City:
Australia
Theme:
Medical Travel, Blood Products, SCIg
Document Type:
Official Guidelines
Organization / Institution:
Australian Red Cross Lifeblood, National Blood Authority, Victorian Government Department of Health
Author:
Victorian Government, Department of Health
Target Audience:
Medical professionals, Patients requiring SCIg
Period of Validity:
Not specified
Date of Approval:
January 2026
Date of Last Update:
January 2026
Version:
HNY v3.0
Replaces version:
HNY v2.0
Clinical content last reviewed:
November 2023
Next review date:
July 2028
Local approval:
1st October 2025
Target population:
Adults aged 18 and over, excluding cancer care
Indications:
Licensed and off-label use in rheumatoid arthritis, Crohn’s disease, psoriasis, psoriatic arthritis, and other chronic inflammatory conditions
Administration routes:
Oral, subcutaneous
Monitoring requirements:
Blood tests, infection screening, vaccination advice, renal function assessment, pregnancy considerations
Responsible organizations:
HNY ICB, RDTC
Document type:
Shared Care Protocol
Contextual description:
Clinical guidance source detailing licensed and off-label methotrexate indications, administration, monitoring, and transfer protocols between specialist and primary care for adults in non-cancer services.
Note:
Version Number 2.3
Year:
2025
Region / City:
United Kingdom
Theme:
Sexual and Reproductive Health
Document Type:
Patient Group Direction (PGD)
Organisation:
Faculty of Sexual and Reproductive Health (FSRH)
Author:
Dr. Cindy Farmer, Michelle Jenkins, Elaine Scott, Kalpesh Thakrar, Sim Sesane, Tanya Lane, Kate Devonport, Chetna Parmar, Carmel Lloyd, Clare Livingstone, Portia Jackson, Kirsty Armstrong, Dipti Patel, Emma Anderson, Alison Crompton, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins, Rosie Furner
Target Audience:
Registered healthcare professionals authorised to practice under this PGD
Period of Effect:
May 2023 - April 2026
Approval Date:
December 2022
Review Date:
October 2025
Expiry Date:
April 2026